Cite

HARVARD Citation

    Aggarwal, R. et al. (2014). Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Annals of the rheumatic diseases. 73 (1), pp. 227-232. [Online]. 
  
Back to record